BLOG
Shaily Engineering Plastics Ltd: Re-designing future growth
Buzzing:
Shaily Engineering is eyeing significant revenue growth over the next four to five years led by the toy and healthcare segment.
Context:
Shaily has earmarked a capex of ~Rs 300 crore in FY22-24 to enhance its toy, healthcare and furnishing business capacities. In the healthcare segment, the company supplies insulin pens to leading pharma companies such as Sanofi and Wockhardt. It has recently added one more global pharma company for the supply of pens in the US. With the new client additions, the company sees 2-3x revenue growth in the health care segment in next three to five years. On the toy side, Shaily has signed a contract with global toy giant Spin Master to supply toys worth ~US$12 million in FY22. At present, the toy segment has insignificant revenues. Shaily sees significant growth opportunities in the toys segment, going forward, as many global companies have started outsourcing from India as a part of their China+1 strategy. Looking at significant growth opportunities, the company has raised Rs 150 crore to fund its capex plans.
Our perspective:
To tap the opportunity in the healthcare and toy business, Shaily is planning to increase its manufacturing capacity in these segments by infusing fresh equity of Rs 150 crore. Venturing into newer segment will further diversify its revenue streams. We believe an uptick in revenue will be aided by new client additions along with increased wallet share from existing global major customer (includes Swedish furnishing major). We build in revenue and PAT CAGR of 27% and 52%, respectively, in FY21-24E led by execution of new orders. Further, strong earnings growth and repayment of debt will improve RoCE and RoE of the company, going forward.
Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Related content
Blogs
Articles - Stocks
Advantages and Disadvantages of NPS
It is a long established fact that a reader will be distracted by the readable content of a page when looking at it...
Articles - Stocks
Advantages and Disadvantages of NPS
It is a long established fact that a reader will be distracted by the readable content of a page when looking at it...
Articles - Stocks
Advantages and Disadvantages of NPS
It is a long established fact that a reader will be distracted by the readable content of a page when looking at it...
Video
Video - Stocks
What is Book Value?
Book Value Explained – Find out what is book value in stocks in this video by ICICIdirect.com.
Video - Stocks
What is Book Value?
Book Value Explained – Find out what is book value in stocks in this video by ICICIdirect.com.
Video - Stocks
What is Book Value?
Book Value Explained – Find out what is book value in stocks in this video by ICICIdirect.com.